DNA enters blood
Every cell sheds small DNA fragments into the bloodstream, creating a snapshot of activity throughout the body.3
Testing & Tracking
Galleri Multi-Cancer Early Detection Test Rx
Screen for a signal shared by 50+ cancer types–often before symptoms appear–with one simple blood draw, giving you more opportunity to find something earlier and take action.
Starting at
$949
- One-time charge
- Quest Diagnostics lab visit and blood draw
- Results in about two weeks
- HSA / FSA
Screens for 50+ cancer types, including many without routine screening¹
Most cancers Galleri detected were caught at an early, more treatable stage²
Predicts where in the body a detected signal may be coming from
HSA / FSA
Ongoing, expert support
Unlimited provider messaging
Free, discreet shipping
Frequently asked questions
What does the Galleri test screen for, and how does it work?
Galleri looks at a single blood draw for cell-free DNA fragments carrying methylation patterns associated with cancer, patterns that can show up before other symptoms do.3 It’s designed to screen for a signal shared across more than 50 types of cancer at once. When a signal is present, the test can also help predict where in the body it’s likely coming from, which helps guide what your provider does next.1
How accurate is the Galleri test?
Accuracy varies by cancer type and stage. In GRAIL’s PATHFINDER 2 study, Galleri detected a signal in about 74% of the twelve cancers responsible for most cancer deaths, and around 40% across all cancer types studied together. Specificity was high, over 99%, meaning a signal detected result is rarely a false alarm.1
And when Galleri does detect something, related research found the majority of those cancers were caught at an early, more treatable stage, with another study showing meaningful reduction in late-stage (Stage 4) diagnoses.2 Still, no test like this catches everything, which is exactly why it’s designed to work alongside your other screenings rather than in place of them.
Is the Galleri test FDA-approved?
<span style=”font-weight: 400;”>No, Galleri has not been cleared or approved by the FDA. It’s offered as a laboratory-developed test, which operates under a different regulatory framework (CLIA) than an FDA-approved drug or device. GRAIL has submitted PATHFINDER 2 data to the FDA as part of a formal approval application </span><span style=”font-weight: 400;”>expected to complete in 2026</span><span style=”font-weight: 400;”>, so the regulatory picture is actively evolving, but as of now, no FDA clearance exists.<sup>1</sup></span>
Usage instructions
View all FAQs
If approved, your collection kit will be mailed to you. Schedule your blood draw at a participating Quest Diagnostics location and bring the complete kit with you. Results are generally available about two weeks after your sample reaches the GRAIL laboratory.
If prescribed, a US-licensed medical provider will provide specific instructions with your care plan.
Important safety information and common side effects
The test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider.
The test is intended to detect cancer signals and predict where in the body the cancer signal is located. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “Cancer Signal Not Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur.
This test is available by prescription only. Additionally, the information above is only a summary and may not contain all important safety information. To learn more, please visit Galleri’s safety information page.
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Disclaimer
Products require an online evaluation with a licensed medical professional who will determine if a product and/or prescription is appropriate.
What is the Galleri Multi-Cancer Early Detection Test?
Most cancer deaths come from cancers that don’t have a recommended screening test.4
Galleri uses one blood draw to screen for a signal shared by 50+ cancer types—giving you an opportunity to find something earlier and act sooner.1
5-year cancer-specific survival when cancer is diagnosed before it spreads5
4x higher
How Galleri Multi-Cancer Early Detection works
Cancer leaves clues
Cancer can alter chemical tags on DNA, called methylation patterns, leaving behind a distinct biological signal.3
Galleri finds patterns
From one blood draw, Galleri analyzes these patterns for a signal shared by 50+ cancer types.1
Origin is predicted
If a signal is detected, Galleri predicts the tissue or organ where it may be coming from, with roughly 88% accuracy in published research.6
Chances improve
Finding cancer before it spreads and before symptoms can mean more options, more time, and a better chance to get ahead of it.
DNA enters blood
Every cell sheds small DNA fragments into the bloodstream, creating a snapshot of activity throughout the body.3
Cancer leaves clues
Cancer can alter chemical tags on DNA, called methylation patterns, leaving behind a distinct biological signal.3
Galleri finds patterns
From one blood draw, Galleri analyzes these patterns for a signal shared by 50+ cancer types.1
Origin is predicted
If a signal is detected, Galleri predicts the tissue or organ where it may be coming from, with roughly 88% accuracy in published research.6
Chances improve
Finding cancer before it spreads and before symptoms can mean more options, more time, and a better chance to get ahead of it.
Results that can change what comes next
- 0
- cancer types screened with one simple blood draw¹
- 0
- new Galleri detected cancers caught at an early stage (Stage I-III)²
- 0
- cancer deaths that come from cancers without recommended screening⁷
We’re leading the way in preventive care
We believe the best time to protect your health is before symptoms narrow your options. In cancer, that window matters. Five-year survival is up to 4x higher when cancer is diagnosed early, yet almost 3/4 of cancers have no recommended screening today, which is where our team of experts comes in.5 7
In-house clinical team with 199+ years of combined experience guiding your care
Stanford PhD-led Research Team with 11 in-house studies and 9 peer-reviewed publications
Trusted by 220,000+ people for proactive, clinician-guided care
Clinically studied
The science of Galleri Multi-Cancer Early Detection Test
Every cell releases small fragments of DNA into the bloodstream. What makes Galleri interesting is that it does not simply count those fragments. It studies the chemical patterns attached to them, called methylation.3
Methylation helps regulate how cells behave, and cancer can change them in recognizable ways. Galleri uses machine learning to distinguish patterns commonly associated with cancer.1 3 If Galleri detects a signal, it predicts one of 18 possible Cancer Signal Origins—the tissue or organ where that signal is most likely coming from—with roughly 88% accuracy in published research.6 9
How it works
Choosing how you age starts here
1
Clinician-led
Connect with a clinician
Share your medical history and risk factors. A US-licensed medical provider will review your information to determine whether Galleri is appropriate.
2
One simple blood draw
Visit a lab location
Your Galleri collection kit arrives by mail. Bring it to a participating lab location for one standard blood draw. No fasting or special preparation is required.
3
Clear next steps
Receive your results
You’ll receive your results within 2 weeks with either a No Cancer Signal or Cancer Signal Detected. If a signal is found, the result will include its predicted origin for you to talk further with your provider.
Get Started
Disclaimer
The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. See above for important safety information. Benefits outlined on AgelessRx.com are based on 3rd party studies. Actual product packaging may appear differently than shown.
More options
Advanced testing, personalized.
iollo Advanced At-Home Metabolic Test
Measure 600+ advanced biomarkers across 19 health areas in one at-home test for personalized insights into how each of your organ systems is aging, where your health may need attention, and what to do next.
Starting at $399
TruMe™ At-Home Saliva Biological Age Test
Reveal your biological age with a simple, pain-free at-home saliva test that measures specific locations on your DNA for deeper insights into your overall health and longevity.
Starting at $170/ kit
Core Longevity Panel
Measure 40+ biomarkers across heart, metabolic, liver, kidney, inflammation, bone, and blood health, including advanced markers your annual labs may not routinely cover.
Starting at $95
Biological Age Blood Test
Your birthday tells you how long you’ve lived. PhenoAge testing helps reveal how your body is aging beneath, so you can stop guessing, establish a baseline, and track what changes over time.
Starting at $75
Continuous Glucose Monitor (CGM)
Take control of your glucose, weight, and metabolic health with continuous glucose monitoring, expert dietitian support, and powerful insights—all in one program with Nutrisense.
Starting at $99/ mo
Frequently asked questions
Galleri is generally recommended for adults with an elevated risk of cancer, most often those 50 and older, since cancer risk rises with age.10 It requires a prescription, so your provider reviews your health history during an online evaluation to help determine whether it’s an appropriate fit for your specific situation before moving forward.
After your online evaluation, if you’re approved, you’ll get a blood draw kit and schedule your draw at a nearby lab. Your sample goes to GRAIL’s lab for analysis, and results typically land in your AgelessRx portal, along with an email notification, about two weeks after your sample arrives.
A “signal detected” result isn’t a cancer diagnosis, it means the test found a pattern worth investigating further. Galleri’s ability to predict where a signal likely originated helps that follow-up start in a more targeted place rather than from scratch.
No. Galleri is designed to work in addition to the screenings you already do—mammograms, colonoscopies, Pap smears, and others—not instead of them. It doesn’t detect every cancer, and it isn’t a substitute for the screening schedule your provider already recommends based on your age and personal risk factors.
Our idea of Friday night?
Fact-checking footnotes.
We vet everything on PubMed so you don’t have to. Here’s what the science says.